Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE- COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
ANGELA, MC Rose, Nathalie NICOLAY, Virginia Sandonis MARTIN, Clara MAZAGATOS, Goranka PETROVIC et. al.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE- COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
Autoři
ANGELA, MC Rose, Nathalie NICOLAY, Virginia Sandonis MARTIN, Clara MAZAGATOS, Goranka PETROVIC, Joaquin BARUCH, Sarah DENAYER, Lucie SEYLER, Lisa DOMEGAN, Odile LAUNAY, Ausenda MACHADO, Cristina BURGUI, Roberta VAIKUTYTE, F Annabel NIESSEN, Isabela I LOGHIN, Petr HUSA (203 Česká republika, domácí), Nassera AOUALI, George PANAGIOTAKOPOULOS, Kristin TOLKSDORF, Judit Krisztina HORVATH, Jennifer HOWARD, Francisco POZO, Virtudes GALLARDO, Diana NONKOVIC, Ausra DZIUGYTE, Nathalie BOSSUYT, Thomas DEMUYSER, Roisin DUFFY, Liem binh Luong NGUYEN, Irina KISLAYA, Ivan MARTINEZ-BAZ, Giedre GEFENAITE, Mirjam J KNOL, Corneliu POPESCU, Lenka SOUČKOVÁ (203 Česká republika), Marc SIMON, Stella MICHELAKI, Janine REICHE, Annamaria FERENCZI, Concepcion DELGADO-SANZ, Zvjezdana Lovric MAKARIC, John Paul CAUCHI, Cyril BARBEZANGE, Van Nedervelde ELS, Joan DONNELL, Christine DURIER, Raquel GUIOMAR, Jesus CASTILLA, Indre JONIKAITE, Patricia C J L BRUIJNING-VERHAGEN, Mihaela LAZAR, Regina DEMLOVÁ (203 Česká republika, domácí), Gil WIRTZ, Marina AMERALI, Ralf DUERRWALD, Mihaly Pal KUNSTAR, Esther KISSLING, Sabrina BACCI, Marta VALENCIANO, Svjetlana KARABUVA, Suzana MLADINOV, Johko MARKIC, Petra Tomah PETRIC, Irena TABAIN, Maja ILIC, Ivan MLINARIC, Petra SMOLJO, Iva Pem NOVOSEL, Tanya MELILLO, Maria-Louise BORG, Benedicte LISSOIR, Xavier HOLEMANS, Marc HAINAUT, Nicolas DAUBY, Benedicte DELAERE, Marc BOURGEOIS, Evelyn PETIT, Marijke REYNDERS, Door JOUCK, Koen MAGERMAN, Marieke BLEYEN, Melissa VERMEULEN, Sebastien FIERENS, Francois DUFRASNE, Siel DAELEMANS, Ala'a Al KERWI, Francoise BERTHET, Guy FAGHERAZZI, Myriam ALEXANDRE, Charlene BENNETT, Jim CHRISTLE, Jeff CONNELL, Peter DORAN, Laura FEENEY, Binita MAHARJAN, Sinead MCDERMOTT, Rosa MCNAMARA, Nadra NURDIN, Zineb LESIEUR, Salif Mamadou CISSE, Anne-Sophie HONNEUR, Xavier DUVAL, Yolande COSTA, Fidouh NADHIRA, Florence GALTIER, Laura CRANTELLE, Vincent FOULONGNE, Phillipe VANHEMS, Selilah AMOUR, Bruno LINA, Fabrice LAINE, Laetitia GALLAIS, Gisele LAGATHU, Anna MAISA, Sibylle BERNARD-STOECKLIN, Yacine SAIDI, Rebecca BAUER, Ana Paula RODRIGUES, Adriana SILVA, Veronica GOMEZ, Margarida TAVARES, Debora PEREIRA, Maria Jose MANATA, Heidi GRUNER, Andre ALMEIDA, Paula PINTO, Cristina BARBARA, Ana MIQUELEIZ, Ana NAVASCUES, Camino TROBAJO-SANMARTIN, Carmen EZPELETA, Nerea EGUEES, Manuel Garcia CENOZ, Eva ARDANAZ, Marcela GUEVARA, Conchi MORENO-IRIBAS, Itziar CASADO, Aukse MICKIENE, Monika KULIESE, Hana ORLIKOVA, Carmen Mihaela DOROBAT, Carmen MANCIUC, Simin Aysel FLORESCU, Alexandru MARIN, Sorin DINU, Catalina PASCU, Alina IVANCIUC, Iulia BISTRICEANU, Mihaela OPREA, Maria Elena MIHAI, Silke BUDA, Ute PREUSS, Marianne WEDDE, Beatrix OROSZI, Katalin KRISZTALOVICS, Gergo TURI, Katalin KRISTOF, Csaba VARGA, Ruoran LI, Alain MOREN a Anthony NARDONE
Vydání
EUROSURVEILLANCE, STOCKHOLM, EUR CENTRE DIS PREVENTION & CONTROL, 2023, 1025-496X
Introduction: The I-MOVE-COVID-19 and VEBIS hospital networks have been measuring COVID-19 vaccine effectiveness (VE) in participating European countries since early 2021. Aim: We aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients >= 20 years hospitalised with severe acute respiratory infection (SARI) from December 2021 to July 2022 (Omicron-dominant period). Methods: In both networks, 46 hospitals (13 countries) follow a similar test-negative case-control protocol. We defined complete primary series vaccination (PSV) and first booster dose vaccination as last dose of either vaccine received >= 14 days before symptom onset (stratifying first booster into received < 150 and >= 150 days after last PSV dose). We measured VE overall, by vaccine category/product, age group and time since first mRNA booster dose, adjusting by site as a fixed effect, and by swab date, age, sex, and presence/absence of at least one commonly collected chronic condition. Results: We included 2,779 cases and 2,362 controls. The VE of all vaccine products combined against hospitalisation for laboratory-confirmed SARS-CoV-2 was 43% (95% CI: 29-54) for complete PSV (with last dose received >= 150 days before onset), while it was 59% (95% CI: 51-66) after addition of one booster dose. The VE was 85% (95% CI: 78-89), 70% (95% CI: 61-77) and 36% (95% CI: 17-51) for those with onset 14-59 days, 60-119 days and 120-179 days after booster vaccination, respectively. Conclusions: Our results suggest that, during the Omicron period, observed VE against SARI hospitalisation improved with first mRNA booster dose, particularly for those having symptom onset < 120 days after first booster dose.
ANGELA, MC Rose, Nathalie NICOLAY, Virginia Sandonis MARTIN, Clara MAZAGATOS, Goranka PETROVIC, Joaquin BARUCH, Sarah DENAYER, Lucie SEYLER, Lisa DOMEGAN, Odile LAUNAY, Ausenda MACHADO, Cristina BURGUI, Roberta VAIKUTYTE, F Annabel NIESSEN, Isabela I LOGHIN, Petr HUSA, Nassera AOUALI, George PANAGIOTAKOPOULOS, Kristin TOLKSDORF, Judit Krisztina HORVATH, Jennifer HOWARD, Francisco POZO, Virtudes GALLARDO, Diana NONKOVIC, Ausra DZIUGYTE, Nathalie BOSSUYT, Thomas DEMUYSER, Roisin DUFFY, Liem binh Luong NGUYEN, Irina KISLAYA, Ivan MARTINEZ-BAZ, Giedre GEFENAITE, Mirjam J KNOL, Corneliu POPESCU, Lenka SOUČKOVÁ, Marc SIMON, Stella MICHELAKI, Janine REICHE, Annamaria FERENCZI, Concepcion DELGADO-SANZ, Zvjezdana Lovric MAKARIC, John Paul CAUCHI, Cyril BARBEZANGE, Van Nedervelde ELS, Joan DONNELL, Christine DURIER, Raquel GUIOMAR, Jesus CASTILLA, Indre JONIKAITE, Patricia C J L BRUIJNING-VERHAGEN, Mihaela LAZAR, Regina DEMLOVÁ, Gil WIRTZ, Marina AMERALI, Ralf DUERRWALD, Mihaly Pal KUNSTAR, Esther KISSLING, Sabrina BACCI, Marta VALENCIANO, Svjetlana KARABUVA, Suzana MLADINOV, Johko MARKIC, Petra Tomah PETRIC, Irena TABAIN, Maja ILIC, Ivan MLINARIC, Petra SMOLJO, Iva Pem NOVOSEL, Tanya MELILLO, Maria-Louise BORG, Benedicte LISSOIR, Xavier HOLEMANS, Marc HAINAUT, Nicolas DAUBY, Benedicte DELAERE, Marc BOURGEOIS, Evelyn PETIT, Marijke REYNDERS, Door JOUCK, Koen MAGERMAN, Marieke BLEYEN, Melissa VERMEULEN, Sebastien FIERENS, Francois DUFRASNE, Siel DAELEMANS, Ala'a Al KERWI, Francoise BERTHET, Guy FAGHERAZZI, Myriam ALEXANDRE, Charlene BENNETT, Jim CHRISTLE, Jeff CONNELL, Peter DORAN, Laura FEENEY, Binita MAHARJAN, Sinead MCDERMOTT, Rosa MCNAMARA, Nadra NURDIN, Zineb LESIEUR, Salif Mamadou CISSE, Anne-Sophie HONNEUR, Xavier DUVAL, Yolande COSTA, Fidouh NADHIRA, Florence GALTIER, Laura CRANTELLE, Vincent FOULONGNE, Phillipe VANHEMS, Selilah AMOUR, Bruno LINA, Fabrice LAINE, Laetitia GALLAIS, Gisele LAGATHU, Anna MAISA, Sibylle BERNARD-STOECKLIN, Yacine SAIDI, Rebecca BAUER, Ana Paula RODRIGUES, Adriana SILVA, Veronica GOMEZ, Margarida TAVARES, Debora PEREIRA, Maria Jose MANATA, Heidi GRUNER, Andre ALMEIDA, Paula PINTO, Cristina BARBARA, Ana MIQUELEIZ, Ana NAVASCUES, Camino TROBAJO-SANMARTIN, Carmen EZPELETA, Nerea EGUEES, Manuel Garcia CENOZ, Eva ARDANAZ, Marcela GUEVARA, Conchi MORENO-IRIBAS, Itziar CASADO, Aukse MICKIENE, Monika KULIESE, Hana ORLIKOVA, Carmen Mihaela DOROBAT, Carmen MANCIUC, Simin Aysel FLORESCU, Alexandru MARIN, Sorin DINU, Catalina PASCU, Alina IVANCIUC, Iulia BISTRICEANU, Mihaela OPREA, Maria Elena MIHAI, Silke BUDA, Ute PREUSS, Marianne WEDDE, Beatrix OROSZI, Katalin KRISZTALOVICS, Gergo TURI, Katalin KRISTOF, Csaba VARGA, Ruoran LI, Alain MOREN a Anthony NARDONE. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE- COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022. EUROSURVEILLANCE. STOCKHOLM: EUR CENTRE DIS PREVENTION & CONTROL, 2023, roč. 28, č. 47, s. 1-17. ISSN 1025-496X. Dostupné z: https://dx.doi.org/10.2807/1560-7917.ES.2023.28.47.2300187.
@article{2348564, author = {Angela, MC Rose and Nicolay, Nathalie and Martin, Virginia Sandonis and Mazagatos, Clara and Petrovic, Goranka and Baruch, Joaquin and Denayer, Sarah and Seyler, Lucie and Domegan, Lisa and Launay, Odile and Machado, Ausenda and Burgui, Cristina and Vaikutyte, Roberta and Niessen, F Annabel and Loghin, Isabela I and Husa, Petr and Aouali, Nassera and Panagiotakopoulos, George and Tolksdorf, Kristin and Horvath, Judit Krisztina and Howard, Jennifer and Pozo, Francisco and Gallardo, Virtudes and Nonkovic, Diana and Dziugyte, Ausra and Bossuyt, Nathalie and Demuyser, Thomas and Duffy, Roisin and Nguyen, Liem binh Luong and Kislaya, Irina and MartinezandBaz, Ivan and Gefenaite, Giedre and Knol, Mirjam J and Popescu, Corneliu and Součková, Lenka and Simon, Marc and Michelaki, Stella and Reiche, Janine and Ferenczi, Annamaria and DelgadoandSanz, Concepcion and Makaric, Zvjezdana Lovric and Cauchi, John Paul and Barbezange, Cyril and Els, Van Nedervelde and Donnell, Joan and Durier, Christine and Guiomar, Raquel and Castilla, Jesus and Jonikaite, Indre and BruijningandVerhagen, Patricia C J L and Lazar, Mihaela and Demlová, Regina and Wirtz, Gil and Amerali, Marina and Duerrwald, Ralf and Kunstar, Mihaly Pal and Kissling, Esther and Bacci, Sabrina and Valenciano, Marta and Karabuva, Svjetlana and Mladinov, Suzana and Markic, Johko and Petric, Petra Tomah and Tabain, Irena and Ilic, Maja and Mlinaric, Ivan and Smoljo, Petra and Novosel, Iva Pem and Melillo, Tanya and Borg, MariaandLouise and Lissoir, Benedicte and Holemans, Xavier and Hainaut, Marc and Dauby, Nicolas and Delaere, Benedicte and Bourgeois, Marc and Petit, Evelyn and Reynders, Marijke and Jouck, Door and Magerman, Koen and Bleyen, Marieke and Vermeulen, Melissa and Fierens, Sebastien and Dufrasne, Francois and Daelemans, Siel and Kerwi, Ala'a Al and Berthet, Francoise and Fagherazzi, Guy and Alexandre, Myriam and Bennett, Charlene and Christle, Jim and Connell, Jeff and Doran, Peter and Feeney, Laura and Maharjan, Binita and Mcdermott, Sinead and Mcnamara, Rosa and Nurdin, Nadra and Lesieur, Zineb and Cisse, Salif Mamadou and Honneur, AnneandSophie and Duval, Xavier and Costa, Yolande and Nadhira, Fidouh and Galtier, Florence and Crantelle, Laura and Foulongne, Vincent and Vanhems, Phillipe and Amour, Selilah and Lina, Bruno and Laine, Fabrice and Gallais, Laetitia and Lagathu, Gisele and Maisa, Anna and BernardandStoecklin, Sibylle and Saidi, Yacine and Bauer, Rebecca and Rodrigues, Ana Paula and Silva, Adriana and Gomez, Veronica and Tavares, Margarida and Pereira, Debora and Manata, Maria Jose and Gruner, Heidi and Almeida, Andre and Pinto, Paula and Barbara, Cristina and Miqueleiz, Ana and Navascues, Ana and TrobajoandSanmartin, Camino and Ezpeleta, Carmen and Eguees, Nerea and Cenoz, Manuel Garcia and Ardanaz, Eva and Guevara, Marcela and MorenoandIribas, Conchi and Casado, Itziar and Mickiene, Aukse and Kuliese, Monika and Orlikova, Hana and Dorobat, Carmen Mihaela and Manciuc, Carmen and Florescu, Simin Aysel and Marin, Alexandru and Dinu, Sorin and Pascu, Catalina and Ivanciuc, Alina and Bistriceanu, Iulia and Oprea, Mihaela and Mihai, Maria Elena and Buda, Silke and Preuss, Ute and Wedde, Marianne and Oroszi, Beatrix and Krisztalovics, Katalin and Turi, Gergo and Kristof, Katalin and Varga, Csaba and Li, Ruoran and Moren, Alain and Nardone, Anthony}, article_location = {STOCKHOLM}, article_number = {47}, doi = {http://dx.doi.org/10.2807/1560-7917.ES.2023.28.47.2300187}, keywords = {COVID-19; Europe; hospital; omicron; SARS-CoV-2; vaccine effectiveness}, language = {eng}, issn = {1025-496X}, journal = {EUROSURVEILLANCE}, title = {Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE- COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022}, url = {https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2023.28.47.2300187}, volume = {28}, year = {2023} }
TY - JOUR ID - 2348564 AU - Angela, MC Rose - Nicolay, Nathalie - Martin, Virginia Sandonis - Mazagatos, Clara - Petrovic, Goranka - Baruch, Joaquin - Denayer, Sarah - Seyler, Lucie - Domegan, Lisa - Launay, Odile - Machado, Ausenda - Burgui, Cristina - Vaikutyte, Roberta - Niessen, F Annabel - Loghin, Isabela I - Husa, Petr - Aouali, Nassera - Panagiotakopoulos, George - Tolksdorf, Kristin - Horvath, Judit Krisztina - Howard, Jennifer - Pozo, Francisco - Gallardo, Virtudes - Nonkovic, Diana - Dziugyte, Ausra - Bossuyt, Nathalie - Demuyser, Thomas - Duffy, Roisin - Nguyen, Liem binh Luong - Kislaya, Irina - Martinez-Baz, Ivan - Gefenaite, Giedre - Knol, Mirjam J - Popescu, Corneliu - Součková, Lenka - Simon, Marc - Michelaki, Stella - Reiche, Janine - Ferenczi, Annamaria - Delgado-Sanz, Concepcion - Makaric, Zvjezdana Lovric - Cauchi, John Paul - Barbezange, Cyril - Els, Van Nedervelde - Donnell, Joan - Durier, Christine - Guiomar, Raquel - Castilla, Jesus - Jonikaite, Indre - Bruijning-Verhagen, Patricia C J L - Lazar, Mihaela - Demlová, Regina - Wirtz, Gil - Amerali, Marina - Duerrwald, Ralf - Kunstar, Mihaly Pal - Kissling, Esther - Bacci, Sabrina - Valenciano, Marta - Karabuva, Svjetlana - Mladinov, Suzana - Markic, Johko - Petric, Petra Tomah - Tabain, Irena - Ilic, Maja - Mlinaric, Ivan - Smoljo, Petra - Novosel, Iva Pem - Melillo, Tanya - Borg, Maria-Louise - Lissoir, Benedicte - Holemans, Xavier - Hainaut, Marc - Dauby, Nicolas - Delaere, Benedicte - Bourgeois, Marc - Petit, Evelyn - Reynders, Marijke - Jouck, Door - Magerman, Koen - Bleyen, Marieke - Vermeulen, Melissa - Fierens, Sebastien - Dufrasne, Francois - Daelemans, Siel - Kerwi, Ala'a Al - Berthet, Francoise - Fagherazzi, Guy - Alexandre, Myriam - Bennett, Charlene - Christle, Jim - Connell, Jeff - Doran, Peter - Feeney, Laura - Maharjan, Binita - Mcdermott, Sinead - Mcnamara, Rosa - Nurdin, Nadra - Lesieur, Zineb - Cisse, Salif Mamadou - Honneur, Anne-Sophie - Duval, Xavier - Costa, Yolande - Nadhira, Fidouh - Galtier, Florence - Crantelle, Laura - Foulongne, Vincent - Vanhems, Phillipe - Amour, Selilah - Lina, Bruno - Laine, Fabrice - Gallais, Laetitia - Lagathu, Gisele - Maisa, Anna - Bernard-Stoecklin, Sibylle - Saidi, Yacine - Bauer, Rebecca - Rodrigues, Ana Paula - Silva, Adriana - Gomez, Veronica - Tavares, Margarida - Pereira, Debora - Manata, Maria Jose - Gruner, Heidi - Almeida, Andre - Pinto, Paula - Barbara, Cristina - Miqueleiz, Ana - Navascues, Ana - Trobajo-Sanmartin, Camino - Ezpeleta, Carmen - Eguees, Nerea - Cenoz, Manuel Garcia - Ardanaz, Eva - Guevara, Marcela - Moreno-Iribas, Conchi - Casado, Itziar - Mickiene, Aukse - Kuliese, Monika - Orlikova, Hana - Dorobat, Carmen Mihaela - Manciuc, Carmen - Florescu, Simin Aysel - Marin, Alexandru - Dinu, Sorin - Pascu, Catalina - Ivanciuc, Alina - Bistriceanu, Iulia - Oprea, Mihaela - Mihai, Maria Elena - Buda, Silke - Preuss, Ute - Wedde, Marianne - Oroszi, Beatrix - Krisztalovics, Katalin - Turi, Gergo - Kristof, Katalin - Varga, Csaba - Li, Ruoran - Moren, Alain - Nardone, Anthony PY - 2023 TI - Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE- COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022 JF - EUROSURVEILLANCE VL - 28 IS - 47 SP - 1-17 EP - 1-17 PB - EUR CENTRE DIS PREVENTION & CONTROL SN - 1025496X KW - COVID-19 KW - Europe KW - hospital KW - omicron KW - SARS-CoV-2 KW - vaccine effectiveness UR - https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2023.28.47.2300187 N2 - Introduction: The I-MOVE-COVID-19 and VEBIS hospital networks have been measuring COVID-19 vaccine effectiveness (VE) in participating European countries since early 2021. Aim: We aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients >= 20 years hospitalised with severe acute respiratory infection (SARI) from December 2021 to July 2022 (Omicron-dominant period). Methods: In both networks, 46 hospitals (13 countries) follow a similar test-negative case-control protocol. We defined complete primary series vaccination (PSV) and first booster dose vaccination as last dose of either vaccine received >= 14 days before symptom onset (stratifying first booster into received < 150 and >= 150 days after last PSV dose). We measured VE overall, by vaccine category/product, age group and time since first mRNA booster dose, adjusting by site as a fixed effect, and by swab date, age, sex, and presence/absence of at least one commonly collected chronic condition. Results: We included 2,779 cases and 2,362 controls. The VE of all vaccine products combined against hospitalisation for laboratory-confirmed SARS-CoV-2 was 43% (95% CI: 29-54) for complete PSV (with last dose received >= 150 days before onset), while it was 59% (95% CI: 51-66) after addition of one booster dose. The VE was 85% (95% CI: 78-89), 70% (95% CI: 61-77) and 36% (95% CI: 17-51) for those with onset 14-59 days, 60-119 days and 120-179 days after booster vaccination, respectively. Conclusions: Our results suggest that, during the Omicron period, observed VE against SARI hospitalisation improved with first mRNA booster dose, particularly for those having symptom onset < 120 days after first booster dose. ER -
ANGELA, MC Rose, Nathalie NICOLAY, Virginia Sandonis MARTIN, Clara MAZAGATOS, Goranka PETROVIC, Joaquin BARUCH, Sarah DENAYER, Lucie SEYLER, Lisa DOMEGAN, Odile LAUNAY, Ausenda MACHADO, Cristina BURGUI, Roberta VAIKUTYTE, F Annabel NIESSEN, Isabela I LOGHIN, Petr HUSA, Nassera AOUALI, George PANAGIOTAKOPOULOS, Kristin TOLKSDORF, Judit Krisztina HORVATH, Jennifer HOWARD, Francisco POZO, Virtudes GALLARDO, Diana NONKOVIC, Ausra DZIUGYTE, Nathalie BOSSUYT, Thomas DEMUYSER, Roisin DUFFY, Liem binh Luong NGUYEN, Irina KISLAYA, Ivan MARTINEZ-BAZ, Giedre GEFENAITE, Mirjam J KNOL, Corneliu POPESCU, Lenka SOUČKOVÁ, Marc SIMON, Stella MICHELAKI, Janine REICHE, Annamaria FERENCZI, Concepcion DELGADO-SANZ, Zvjezdana Lovric MAKARIC, John Paul CAUCHI, Cyril BARBEZANGE, Van Nedervelde ELS, Joan DONNELL, Christine DURIER, Raquel GUIOMAR, Jesus CASTILLA, Indre JONIKAITE, Patricia C J L BRUIJNING-VERHAGEN, Mihaela LAZAR, Regina DEMLOVÁ, Gil WIRTZ, Marina AMERALI, Ralf DUERRWALD, Mihaly Pal KUNSTAR, Esther KISSLING, Sabrina BACCI, Marta VALENCIANO, Svjetlana KARABUVA, Suzana MLADINOV, Johko MARKIC, Petra Tomah PETRIC, Irena TABAIN, Maja ILIC, Ivan MLINARIC, Petra SMOLJO, Iva Pem NOVOSEL, Tanya MELILLO, Maria-Louise BORG, Benedicte LISSOIR, Xavier HOLEMANS, Marc HAINAUT, Nicolas DAUBY, Benedicte DELAERE, Marc BOURGEOIS, Evelyn PETIT, Marijke REYNDERS, Door JOUCK, Koen MAGERMAN, Marieke BLEYEN, Melissa VERMEULEN, Sebastien FIERENS, Francois DUFRASNE, Siel DAELEMANS, Ala'a Al KERWI, Francoise BERTHET, Guy FAGHERAZZI, Myriam ALEXANDRE, Charlene BENNETT, Jim CHRISTLE, Jeff CONNELL, Peter DORAN, Laura FEENEY, Binita MAHARJAN, Sinead MCDERMOTT, Rosa MCNAMARA, Nadra NURDIN, Zineb LESIEUR, Salif Mamadou CISSE, Anne-Sophie HONNEUR, Xavier DUVAL, Yolande COSTA, Fidouh NADHIRA, Florence GALTIER, Laura CRANTELLE, Vincent FOULONGNE, Phillipe VANHEMS, Selilah AMOUR, Bruno LINA, Fabrice LAINE, Laetitia GALLAIS, Gisele LAGATHU, Anna MAISA, Sibylle BERNARD-STOECKLIN, Yacine SAIDI, Rebecca BAUER, Ana Paula RODRIGUES, Adriana SILVA, Veronica GOMEZ, Margarida TAVARES, Debora PEREIRA, Maria Jose MANATA, Heidi GRUNER, Andre ALMEIDA, Paula PINTO, Cristina BARBARA, Ana MIQUELEIZ, Ana NAVASCUES, Camino TROBAJO-SANMARTIN, Carmen EZPELETA, Nerea EGUEES, Manuel Garcia CENOZ, Eva ARDANAZ, Marcela GUEVARA, Conchi MORENO-IRIBAS, Itziar CASADO, Aukse MICKIENE, Monika KULIESE, Hana ORLIKOVA, Carmen Mihaela DOROBAT, Carmen MANCIUC, Simin Aysel FLORESCU, Alexandru MARIN, Sorin DINU, Catalina PASCU, Alina IVANCIUC, Iulia BISTRICEANU, Mihaela OPREA, Maria Elena MIHAI, Silke BUDA, Ute PREUSS, Marianne WEDDE, Beatrix OROSZI, Katalin KRISZTALOVICS, Gergo TURI, Katalin KRISTOF, Csaba VARGA, Ruoran LI, Alain MOREN a Anthony NARDONE. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE- COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022. \textit{EUROSURVEILLANCE}. STOCKHOLM: EUR CENTRE DIS PREVENTION \&{} CONTROL, 2023, roč.~28, č.~47, s.~1-17. ISSN~1025-496X. Dostupné z: https://dx.doi.org/10.2807/1560-7917.ES.2023.28.47.2300187.